Editorial: Cancer genomics in the era of precision medicine.
作者信息
Khan Omar M, Mallardo Domenico, Decock Julie
机构信息
College of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.
Department of Melanoma, Cancer Immunotherapy and Development Therapeutics INT IRCCS Fondazione "G Pascale", Napoli, Italy.
出版信息
Front Genet. 2024 Feb 16;15:1378917. doi: 10.3389/fgene.2024.1378917. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Cancer genomics in the era of precision medicine.
Front Genet. 2024 Feb 16;15:1378917. doi: 10.3389/fgene.2024.1378917. eCollection 2024.
2
Starring Role of Biomarkers and Anticancer Agents as a Major Driver in Precision Medicine of Cancer Therapy.
Curr Mol Med. 2023;23(2):111-126. doi: 10.2174/1566524022666211221152947.
3
[The promise of omics in the precision medicine era].
Rev Med Interne. 2022 Nov;43(11):649-660. doi: 10.1016/j.revmed.2022.07.009. Epub 2022 Aug 27.
4
Precision diagnostics: integration of tissue pathology and genomics in cancer.
Pathology. 2021 Dec;53(7):809-817. doi: 10.1016/j.pathol.2021.08.003. Epub 2021 Oct 8.
5
The Role of Pathology in the Era of Personalized (Precision) Medicine: A Brief Review.
Acta Med Acad. 2021 Apr;50(1):47-57. doi: 10.5644/ama2006-124.325.
6
Precision medicine in hearing loss.
J Genet Genomics. 2018 Feb 20;45(2):99-109. doi: 10.1016/j.jgg.2018.02.004. Epub 2018 Feb 16.
7
Are innovation and new technologies in precision medicine paving a new era in patients centric care?
J Transl Med. 2019 Apr 5;17(1):114. doi: 10.1186/s12967-019-1864-9.
8
The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
Adv Exp Med Biol. 2017;1007:59-70. doi: 10.1007/978-3-319-60733-7_4.
9
Precision medicine: what's all the fuss about?
Scand J Clin Lab Invest Suppl. 2016;245:S2-5. doi: 10.1080/00365513.2016.1206434. Epub 2016 Aug 17.
10
Precision Medicine and Personalized Medicine in Cardiovascular Disease.
Adv Exp Med Biol. 2018;1065:589-605. doi: 10.1007/978-3-319-77932-4_36.
引用本文的文献
1
Accelerating cancer genomics research in Sub-Saharan Africa.
Front Oncol. 2025 May 29;15:1531799. doi: 10.3389/fonc.2025.1531799. eCollection 2025.
2
Comparative Analysis of Multi-Omics Integration Using Graph Neural Networks for Cancer Classification.
IEEE Access. 2025;13:37724-37736. doi: 10.1109/access.2025.3540769. Epub 2025 Feb 11.
本文引用的文献
1
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial.
Nat Commun. 2024 Jan 2;15(1):146. doi: 10.1038/s41467-023-44475-6.
2
COLUMBUS 5-year update: a randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF.
Future Oncol. 2023 May;19(16):1091-1098. doi: 10.2217/fon-2022-1258. Epub 2023 Jun 13.
3
Evaluation and comparison of different breast cancer prognosis scores based on gene expression data.
Breast Cancer Res. 2023 Feb 8;25(1):17. doi: 10.1186/s13058-023-01612-9.
4
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma.
Nat Med. 2021 Feb;27(2):256-263. doi: 10.1038/s41591-020-01211-7. Epub 2021 Feb 8.
5
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.
Nat Med. 2020 Apr;26(4):566-576. doi: 10.1038/s41591-020-0805-8. Epub 2020 Apr 6.
6
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Science. 2017 Jul 28;357(6349):409-413. doi: 10.1126/science.aan6733. Epub 2017 Jun 8.
7
Co-development of a companion diagnostic for targeted cancer therapy.
N Biotechnol. 2012 Sep 15;29(6):682-8. doi: 10.1016/j.nbt.2012.02.002. Epub 2012 Feb 25.
Zotero 插件